PLC-XD1 Polyclonal Antibody

    • Catalog No.:YT3796
    • Applications:IHC;IF;ELISA
    • Reactivity:Human;Mouse
      • Target:
      • PLC-XD1
      • Gene Name:
      • PLCXD1
      • Protein Name:
      • PI-PLC X domain-containing protein 1
      • Human Swiss Prot No:
      • Q9NUJ7
      • Mouse Swiss Prot No:
      • Q8CHS4
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human PLCXD1. AA range:187-236
      • Specificity:
      • PLC-XD1 Polyclonal Antibody detects endogenous levels of PLC-XD1 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • PLCXD1;PI-PLC X domain-containing protein 1
      • Molecular Weight(Da):
      • 37kD
      • Background:
      • This gene is the most terminal protein-coding gene in the pseudoautosomal (PAR) region on chromosomes X and Y. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010],
      • Function:
      • miscellaneous:The gene encoding for this protein is located in the pseudoautosomal region 1 (PAR1) of X and Y chromosomes.,similarity:Contains 1 PI-PLC X-box domain.,
      • Subcellular Location:
      • Cytoplasm .
      • Expression:
      • Widely expressed.
      • Products Images
      • Immunohistochemical analysis of paraffin-embedded Human lung cancer. Antibody was diluted at 1:100(4° overnight). High-pressure and temperature Tris-EDTA,pH8.0 was used for antigen retrieval. Negetive contrl (right) obtaned from antibody was pre-absorbed by immunogen peptide.
      • Immunohistochemistry analysis of paraffin-embedded human lung carcinoma, using PLCXD1 Antibody. The picture on the right is blocked with the synthesized peptide.